We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Jul 2020 - 30 Jul 2020

Molecular Diagnostics

Image: Pre-eclampsia: high magnification micrograph of hypertrophic decidual vasculopathy, as seen in pregnancy-induced hypertension. (Photo courtesy of Wikimedia Commons)

Serum MicroRNAs Predict Likelihood of Pregnant Women Developing Pre-Eclampsia

MicroRNA biomarkers have been identified in the blood of asymptomatic pregnant women that can be used to predict the potential onset of pre-eclampsia. More...
02 Jun 2020
Image: Processes underlying multiple sclerosis (Photo courtesy of Wikimedia Commons)

Elevated Plasma Neurofilament Light Chain Predicts Worsening of Muscular Sclerosis Symptoms

A test that measures the amount of neurofilament light chain protein in blood plasma can predict the likelihood of patients with multiple sclerosis (MS) progressing to the more severe forms of the disease. More...
01 Jun 2020
Image: Micrograph of pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer) (Photo courtesy of Wikimedia Commons)

MicroRNA Biomarker Panel Identifies Patients at Risk for Pancreatic Cancer Metastasis to the Lymph Nodes

A team of cancer researchers has identified a microRNA (miRNA) signature panel that identifies patients at risk for pancreatic cancer metastasis to the lymph nodes. More...
26 May 2020
Image: Schematic diagram of how the representative tumor sampling method lessens bias in molecular analyses (Photo courtesy of Francis Crick Institute).

Representative Tumor Sampling Method Lessens Molecular Analyses Bias

Over the past decade, clinical scientists have demonstrated the inability of an individual biopsy or formalin-fixed paraffin-embedded (FFPE) block to capture the genetic diversity of a solid tumor. More...
25 May 2020
Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)

An Analytical Method to Monitor Dietary Fat Intake

An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats. More...
25 May 2020
Image: Germline Risk Variants Found in Prostate Cancer Patients Using the Heredity Testing Kit (Photo courtesy of Invitae).

Germline Risk Variants Found in Prostate Cancer Patients

Studies done over the past five years or so have unearthed pathogenic germline variants in some 12% to 17% of men with prostate cancer, and such alterations can impact everything from the treatment options available to them, to the management strategies used for other members of the same family. More...
21 May 2020
Image: Schematic diagram of the Adenoma-Carcinoma Sequence; a non-invasive blood assay, FirstSightCRC, can detect early colorectal cancer (Photo courtesy of CellMax Life).

Non-Invasive Blood Assay Can Detect Early Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). In general, colon cancer begins when healthy cells in the colon develop changes (mutations) in their DNA and as the cells accumulate, they form a tumor. More...
21 May 2020

Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2020 Globetech Media. All rights reserved.